Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson’s Disease

BACKGROUND: Levodopa (LD) is the most effective drug in the treatment of Parkinson’s disease (PD). Unfortunately, prolonged use of LD leads to complications, mainly motor/non-motor fluctuations (MNMF) and dyskinesias (DYS). Women seem more prone to develop such LD-related complications. Nonetheless,...

Descripción completa

Detalles Bibliográficos
Autores principales: Conti, Valeria, Izzo, Viviana, Russillo, Maria Claudia, Picillo, Marina, Amboni, Marianna, Scaglione, Cesa L. M., Nicoletti, Alessandra, Cani, Ilaria, Cicero, Calogero E., De Bellis, Emanuela, Charlier, Bruno, Giudice, Valentina, Somma, Gerardina, Corbi, Graziamaria, Barone, Paolo, Filippelli, Amelia, Pellecchia, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193593/
https://www.ncbi.nlm.nih.gov/pubmed/35712091
http://dx.doi.org/10.3389/fmed.2022.909936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193593/
https://www.ncbi.nlm.nih.gov/pubmed/35712091
http://dx.doi.org/10.3389/fmed.2022.909936

Ejemplares similares